(Q36349562)

13 August 2017

1 reference

title

Adenovirus p53 gene therapy (English)

1 reference

13 August 2017

0 references

1 reference

Jack A Roth

1

1 reference

PubMed ID

16370914

13 August 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

Expert Opinion on Biological Therapy

13 August 2017

1 reference

13 August 2017

6

1 reference

13 August 2017

55-61

1 reference

13 August 2017

1

1 reference

The p53 pathway and apoptosis

13 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.1.55

Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.1.55

The Bcl-2 protein family: arbiters of cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.1.55

Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.1.55

Prognostic significance of p53 and ras gene abnormalities in lung adenocarcinoma patients with stage I disease after curative resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.1.55

p53 expression and prognosis in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.1.55

Suppression of the immune response to an adenovirus vector and enhancement of intratumoral transgene expression by low-dose etoposide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.1.55

Parenteral gene therapy with p53 inhibits human breast tumors in vivo through a bystander mechanism without evidence of toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.1.55

A novel form of Epstein-Barr virus latency in normal B cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.1.55

Longitudinal follow-up of cellular and humoral immunity induced by recombinant adenovirus-mediated gene therapy in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.1.55

Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.1.55

Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.1.55

Modification of tumor suppressor gene expression and induction of apoptosis in non-small cell lung cancer (NSCLC) with an adenovirus vector expressing wildtype p53 and cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.1.55

Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.1.55

Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.1.55

Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.1.55

Radiation-induced apoptosis: relevance to radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.1.55

Gene therapy for lung cancer: enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.1.55

Role of p53 in the regulation of irradiation-induced apoptosis in neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.1.55

Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.1.55

Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.1.55

Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.1.55

A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.1.55

Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.1.55

21 January 2018

Identifiers

DOI

10.1517/14712598.6.1.55

1 reference

13 August 2017

1 reference

PubMed ID

16370914